Search

Author/Creator Mylonakis, E.

2. Cinnamyl Schiff bases: synthesis, cytotoxic effects and antifungal activity of clinical interest. (10th August 2020)

Authors:
Magalhães, T.F.F.; da Silva, C.M.; dos Santos, L.B.F.; Santos, D.A.; Silva, L.M.; Fuchs, B.B.; Mylonakis, E.; Martins, C.V.B.; de Resende‐Stoianoff, M.A.; de Fátima, Â.
Journal:
Letters in applied microbiology
Issue:
Volume 71:Number 5(2020)
Page Start:
490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cinnamyl Schiff bases: synthesis, cytotoxic effects and antifungal activity of clinical interest. (1st November 2020)

Authors:
Magalhães, T.F.F.; da Silva, C.M.; dos Santos, L.B.F.; Santos, D.A.; Silva, L.M.; Fuchs, B.B.; Mylonakis, E.; Martins, C.V.B.; de Resende‐Stoianoff, M.A.; de Fátima, Â.
Journal:
Letters in applied microbiology
Issue:
Volume 71:Number 5(2020)
Page Start:
490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). (June 2018)

Authors:
Baddley, J.W.; Cantini, F.; Goletti, D.; Gómez-Reino, J.J.; Mylonakis, E.; San-Juan, R.; Fernández-Ruiz, M.; Torre-Cisneros, J.
Journal:
Clinical microbiology and infection
Issue:
Volume 24: Supplement 2(2018)
Page Start:
S10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗